NumerixS Investment Technologies’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,874
Closed -$146K 536
2020
Q2
$146K Buy
+12,874
New +$183K 0.04% 472
2020
Q1
Sell
-4,400
Closed -$120K 1180
2019
Q4
$120K Buy
+4,400
New +$121K 0.02% 628
2019
Q3
Sell
-2,299
Closed -$64K 1160
2019
Q2
$64K Buy
+2,299
New +$64.9K 0.02% 718
2019
Q1
Sell
-4,700
Closed -$134K 1253
2018
Q4
$134K Sell
4,700
-4,377
-48% -$157K 0.04% 472
2018
Q3
$420K Sell
9,077
-5,623
-38% -$250K 0.08% 357
2018
Q2
$546K Buy
14,700
+7,200
+96% +$243K 0.12% 237
2018
Q1
$223K Sell
7,500
-800
-10% -$27.1K 0.06% 369
2017
Q4
$285K Buy
+8,300
New +$280K 0.06% 359
2017
Q3
Sell
-6,400
Closed -$165K 1277
2017
Q2
$165K Sell
6,400
-18,000
-74% -$382K 0.02% 705
2017
Q1
$468K Sell
24,400
-9,100
-27% -$161K 0.05% 441
2016
Q4
$558K Buy
+33,500
New +$606K 0.07% 351
2016
Q3
Sell
-43,500
Closed -$1.33M 1237
2016
Q2
$1.33M Buy
43,500
+14,837
+52% +$515K 0.18% 140
2016
Q1
$1.07M Buy
28,663
+17,763
+163% +$669K 0.12% 222
2015
Q4
$470K Buy
10,900
+2,800
+35% +$118K 0.06% 445
2015
Q3
$304K Buy
+8,100
New +$287K 0.03% 513

Other funds holding MYGN

NumerixS Investment Technologies's MYGN Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Myriad Genetics (MYGN) in Q3 2020, closing a stake of 12,874 shares — an estimated $146K sold.

NumerixS Investment Technologies first reported a position in MYGN in Q3 2015 and held it in 15 quarters. The position peaked at $1.33M in Q2 2016. 192 funds tracked by Wall St. Rank hold MYGN as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Myriad Genetics position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 12,874 Myriad Genetics shares in Q3 2020, an estimated $146K.
  • NumerixS Investment Technologies first reported a position in Myriad Genetics in Q3 2015 and held it in 15 quarters.
  • NumerixS Investment Technologies's Myriad Genetics position peaked at $1.33M in Q2 2016.
  • 192 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.